Oak Thistle LLC Tandem Diabetes Care Inc Transaction History

Oak Thistle LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$22.09 - $35.41 $214,140 - $343,264	-9,694 Reduced 53.11%	8,557 $303,000
Q4 2023 Jan 22, 2024	BUY	$14.28 - $31.03 $260,624 - $566,328	18,251 New	18,251 $539,000
Q2 2023 Jul 26, 2023	BUY	$24.18 - $42.46 $398,776 - $700,250	16,492 Added 202.33%	24,643 $604,000
Q1 2023 Apr 27, 2023	SELL	$35.86 - $46.5 $33,672 - $43,663	-939 Reduced 10.33%	8,151 $331,000
Q4 2022 Feb 06, 2023	BUY	$35.49 - $56.15 $322,604 - $510,403	9,090 New	9,090 $408,000
Q2 2022 Aug 01, 2022	SELL	$53.22 - $123.09 $92,496 - $213,930	-1,738 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$101.89 - $150.09 $177,084 - $260,856	1,738 New	1,738 $202,000

344

72.7M

3.12M

343K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.68B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Oak Thistle LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Thistle LLC with notifications on news.